221
TITLE: Phase II evaluation of topotecan in carcinosarcoma of the uterus: A Gynecologic Oncology Group study  Full Text
AUTHORS: David Scott Miller ; John A Blessing; Jeanne Schilder; Adnan Munkarah; Yi Chun Lee;
PUBLISHED: 2005, SOURCE: Gynecologic Oncology, VOLUME: 98, ISSUE: 2
INDEXED IN: Scopus CrossRef: 44
222
TITLE: Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: A Gynecologic Oncology Group study
AUTHORS: Harry J Long; Brian N Bundy; Edward C Grendys; Jo Ann Benda; Scott S McMeekin; Joel Sorosky; David Scott Miller ; Lynne A Eaton; James V Fiorica; Denise Mackey;
PUBLISHED: 2005, SOURCE: Journal of Clinical Oncology, VOLUME: 23, ISSUE: 21
INDEXED IN: Scopus CrossRef: 434
223
TITLE: Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis  Full Text
AUTHORS: Jayanthi S Lea; Robert Coleman; Aleena Kurien; John O Schorge; David Scott Miller ; John D Minna; Carolyn Y Muller;
PUBLISHED: 2004, SOURCE: American Journal of Obstetrics and Gynecology, VOLUME: 190, ISSUE: 3
INDEXED IN: Scopus CrossRef: 35
224
TITLE: Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study  Full Text
AUTHORS: Franco M Muggia; John A Blessing; Michael Method; David Scott Miller ; Gary A Johnson; Roger B Lee; Andrew Menzin;
PUBLISHED: 2004, SOURCE: Gynecologic Oncology, VOLUME: 92, ISSUE: 2
INDEXED IN: Scopus CrossRef: 44
225
TITLE: Oral dexamethasone attenuates Doxil®-induced palmar-plantar erythrodysesthesias in patients with recurrent gynecologic malignancies  Full Text
AUTHORS: Richard D Drake; Michael M Lin; Melanie King; Diana Farrar; David Scott Miller ; Robert L Coleman;
PUBLISHED: 2004, SOURCE: Gynecologic Oncology, VOLUME: 94, ISSUE: 2
INDEXED IN: Scopus CrossRef: 44
226
TITLE: Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer
AUTHORS: John O Schorge; Richard D Drake; Hang Lee; Steven J Skates; Ramababu Rajanbabu; David Scott Miller ; Jae Hoon Kim; Daniel W Cramer; Ross S Berkowitz; Samuel C Mok;
PUBLISHED: 2004, SOURCE: Clinical Cancer Research, VOLUME: 10, ISSUE: 10
INDEXED IN: Scopus CrossRef: 64
227
TITLE: Other primary malignancies in patients with uterine corpus malignancy  Full Text
AUTHORS: Jacquelyn B Delin; David Scott Miller ; Robert L Coleman;
PUBLISHED: 2004, SOURCE: American Journal of Obstetrics and Gynecology, VOLUME: 190, ISSUE: 5
INDEXED IN: Scopus CrossRef: 3
228
TITLE: P16 as a molecular biomarker of cervical adenocarcinoma  Full Text
AUTHORS: John O Schorge; Jayanthi S Lea; Keren J Elias; Ramababu Rajanbabu; Robert L Coleman; David Scott Miller ; Raheela Ashfaq;
PUBLISHED: 2004, SOURCE: American Journal of Obstetrics and Gynecology, VOLUME: 190, ISSUE: 3
INDEXED IN: Scopus CrossRef: 42
229
TITLE: Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
AUTHORS: David H Moore; John A Blessing; Richard P McQuellon; Howard T Thaler; David Cella; Jo Benda; David Scott Miller ; George Olt; Stephanie King; John F Boggess; Thomas F Rocereto;
PUBLISHED: 2004, SOURCE: Journal of Clinical Oncology, VOLUME: 22, ISSUE: 15
INDEXED IN: Scopus CrossRef: 472
230
TITLE: Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development
AUTHORS: Jayanthi S Lea; Raheela Ashfaq; Sabeeha Muneer; David G Burbee; David Scott Miller ; John D Minna; Carolyn Y Muller;
PUBLISHED: 2004, SOURCE: Journal of the Society for Gynecologic Investigation, VOLUME: 11, ISSUE: 5
INDEXED IN: Scopus CrossRef: 9
Page 23 of 31. Total results: 304.